August 25, 2020
Dr. Shijun Zhang is the recipient of a supplement to his current R01 grant titled 'Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease'. Congratulations Dr. Zhang.
Virginia Commonwealth University School of Pharmacy Institute for Structural Biology, Drug Discovery and Development 800 E. Leigh Street, Suite 212 Richmond, Virginia 23219 Email: email@example.com Phone: 804.828.7575
EditView graphic versionPrivacy | Accessibility | Webmaster